Key result
A smartphone-based micro-mechanical blood clot testing system accurately computed PT and INR with inter-class correlation coefficients of 0.963 and 0.966, respectively, compared to a clinical-grade analyzer.
Why the study?
Frequent PT and INR testing is critical for patients on lifelong warfarin, but reliance on hospital laboratories or expensive point-of-care devices limits frequent and affordable testing.
Does a smartphone-based micro-mechanical testing system accurately measure PT/INR compared to a clinical-grade coagulation analyzer?
Observational (n=299)
Yes
Does a smartphone-based micro-mechanical testing system accurately measure PT/INR compared to a clinical-grade coagulation analyzer?
Effect estimate: R = 0.963 for PT and R = 0.966 for INR
A proof-of-concept smartphone-based system can accurately measure PT/INR from a single drop of blood, offering a potential low-cost alternative for anticoagulation monitoring in low-resource settings.
Smartphone PT/INR testing may enable affordable frequent monitoring; leaves open clinical validation before practice adoption.
Frequent prothrombin time (PT) and international normalized ratio (INR) testing is critical for millions of people on lifelong anticoagulation with warfarin. Currently, testing is performed in hospital laboratories or with expensive point-of-care devices limiting the ability to test frequently and affordably. We report a proof-of-concept PT/INR testing system that uses the vibration motor and camera on smartphones to track micro-mechanical movements of a copper particle. The smartphone system computed the PT/INR with inter-class correlation coefficients of 0.963 and 0.966, compared to a clinical-grade coagulation analyzer for 140 plasma samples and demonstrated similar results for 80 whole blood samples using a single drop of blood (10 μl). When tested with 79 blood samples with coagulopathic conditions, the smartphone system demonstrated a correlation of 0.974 for both PT/INR. Given the ubiquity of smartphones in the global setting, this proof-of-concept technology may provide affordable and effective PT and INR testing in low-resource environments.
No takes yet. Share an insight, caveat, or question.
Chan et al. (2022) conducted an observational in Patients requiring prothrombin time (PT) and international normalized ratio (INR) monitoring (n=299). Smartphone-based micro-mechanical blood clot testing system vs. Clinical-grade coagulation analyzer and commercial point-of-care PT/INR test meter was evaluated on Inter-class correlation coefficient for PT and INR compared to a clinical-grade coagulation analyzer (plasma samples) (R = 0.963 for PT and R = 0.966 for INR). A smartphone-based micro-mechanical blood clot testing system accurately computed PT and INR with inter-class correlation coefficients of 0.963 and 0.966, respectively, compared to a clinical-grade analyzer.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: